Company Filing History:
Years Active: 2025
Title: Innovation in Medical Therapeutics: The Contributions of Abhinandan Danodia
Introduction
Abhinandan Danodia is a notable inventor based in Greater Noida, India. He has made significant contributions in the field of medical therapeutics, particularly through his innovative research and inventions. His work centers around improving treatment methods for conditions related to the dysfunction of specific enzymes.
Latest Patents
Abhinandan Danodia holds one patented invention titled "Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses thereof." This patent describes a set of compounds that are effective in treating conditions correlated with the dysfunction of the ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) enzyme. Specifically, the invention details a compound of formula (J) which demonstrates inhibitory activity against the ENPP1 enzyme. Furthermore, it encompasses methods for treating conditions that arise from the over-expression of the ENPP1 gene, along with the uses of such compounds, pharmaceutical compositions, and associated kits.
Career Highlights
Abhinandan Danodia is associated with 1cBio, Inc., where he has taken on vital roles that contribute to the research and development of advanced therapeutic solutions. His focus on enzyme inhibitors showcases his dedication to addressing unmet medical needs.
Collaborations
Throughout his career, Abhinandan has collaborated with talented professionals such as Brahmam Pujala and Amantullah Ansari. These collaborations have fostered a productive research environment, allowing the development of innovative solutions in the biomedical field.
Conclusion
Abhinandan Danodia’s innovative work in developing ENPP1 inhibitors represents a significant stride towards improving therapeutic options for conditions associated with enzyme dysfunction. His ongoing contributions to the field exemplify the importance of research and collaboration in advancing medical science.